Brief: Pasithea Therapeutics Corp - Filed Its Definitive Consent Revocation Statement With U.S. SEC And Sent A Letter To Pasithea Stockholders
02/08/2022 12:33
Aug 2 (Reuters) - Pasithea Therapeutics Corp KTTA.O :
* PASITHEA THERAPEUTICS CORP - FILED ITS DEFINITIVE CONSENT
REVOCATION STATEMENT WITH U.S. SEC AND SENT A LETTER TO PASITHEA
STOCKHOLDERS
* PASITHEA THERAPEUTICS CORP - BOARD UNANIMOUSLY RECOMMENDS
STOCKHOLDERS TO SIGN, DATE AND RETURN GOLD CONSENT REVOCATION
CARD
Source text for Eikon: ID:nGNX8YjGCY
Further company coverage: KTTA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pasithea Therapeutics
See all newsPasithea Therapeutics Corp reports results for the quarter ended June 30 - Earnings Summary
Pasithea Therapeutics Corp expected to post a loss of 16 cents a share - Earnings Preview
Brief: Pasithea Therapeutics Announces Positive Interim Phase 1 Advanced Cancer Study Data
Brief: Pasithea Therapeutics Announces Closing Of $60 Million Public Offering Of Common Stock
Pasithea Therapeutics jumps after $60 million public offering announcement